RTSN

10.51019.22%
OA

Omar Al Dhaybi

Member of Scientific Advisory Board

Dr. Omar Al Dhaybi, M.D., MSc, FASN, is Member of Scientific Advisory Board of Retension Pharmaceuticals, Inc. from September 2026 and is a Hypertension specialist and Director of the American Heart Association Comprehensive Hypertension Center at Mount Sinai Fuster Heart Hospital, where he serves as Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai and Specialist in hypertension and kidney-related cardiovascular disorders. Dr. Al Dhaybi completed his nephrology fellowship at the University of Chicago, followed by advanced subspecialty training in hypertension at the American Heart Association Comprehensive Hypertension Center at the University of Chicago under Dr. George Bakris. Dr. Al Dhaybi is board certified in hypertension by the American Heart Association. His clinical practice and research focus on resistant and secondary hypertension, including hypertension associated with chronic kidney disease, hypertension associated with endocrine disorders, renovascular disease, autonomic disorders, and hypertension in pregnancy.

Positions